Effects of novel pyridothiazepines and pyridothiazines on contractility of isolated guinea-pig heart muscle and vascular smooth muscle preparations

Biological and Pharmaceutical Bulletin

Volumn 22, Issue 7, 1999, Pages 683-686

  Schade, Bettina ^a   Studenik, Christian ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Aortic ring; Contractile force; Guinea pig; Papillary muscle; Pyridothiazepine; Pyridothiazine

Indexed keywords

1 [N [2 (3,4 DIMETHOXYPHENYL)ETHYL] N METHYLAMINOACETYL] 1,2,3,4 TETRAHYDROPYRIDO[2,3 B][1,4]THIAZEPINE FUMARATE; 1 [N [2 (3,4 DIMETHOXYPHENYL)ETHYL] N METHYLAMINOPROPIONYL] 1,2,3,4 TETRAHYDROPYRIDO[2,3 B][1,4]THIAZEPINE FUMARATE; 2,3 DIHYDRO 1 [N [2 (3,4 DIMETHOXYPHENYL)ETHYL] N METHYLAMINOACETYL] 1H PYRIDO[2,3 B][1,4]THIAZINE FUMARATE; 2,3 DIHYDRO 1 [N [2 (3,4 DIMETHOXYPHENYL)ETHYL] N METHYLAMINOPROPIONYL 1H PYRIDO[2,3 B][1,4]THIAZINE FUMARATE; AMINE; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; MM 10; MM 11; PYRIDOTHIAZEPINE; PYRIDOXINE DERIVATIVE; THIAZEPINE DERIVATIVE; THIAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; DRUG EFFECT; DRUG STRUCTURE; GUINEA PIG; HEART MUSCLE CONTRACTILITY; HEART PAPILLARY MUSCLE; INOTROPISM; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; VASCULAR RING; VASCULAR SMOOTH MUSCLE;

EID: 0032812497     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.22.683     Document Type: Article

References (17)

1. Fleckenstein A., Annu. Rev. Pharmacol. Toxicol., 17, 149-166 (1977).
2. Hashimoto K., Watanabe K., Mochizuki S., Tomiyama A., Jpn. J. Pharmacol., 51, 475-482 (1989).
3. Farber N. E., Gross G. J., J. Pharmacol. Exp. Ther., 248, 39-43 (1989).
4. Pelc L. R., Farber N. E., Warltier D. C., J. Cardiovasc. Pharmacol., 13, 586 (1989).
5. Koch-Weser J., Amer. J. Physiol., 204, 451-457 (1963).
6. Reiter M., Arzneim. Forsch., 17, 1249-1253 (1967).
7. Nakajima H., Hoshiyama M., Yamashita K., Kiyomoto A., Jpn. J. Pharmacol., 25, 383-392 (1975).
8. Kodama I., Shibata S., J. Pharmacol. Exp. Ther., 258, 332-338 (1991).
9. Cheng Y. N., Kiyosue T., Arita M., J. Pharmacol. Exp. Ther., 270, 851-857 (1994).
10. Kodama I., Wakabayashi S., Toyama J., Shibata S., Yamada K., J. Cardiovasc. Pharmacol., 11, 687-693 (1988).
11. Orallo F., Pharmacol. Ther., 69, 153-171 (1996).
12. Van Breemen C., Farinas B. R., Gerba R., Naughton E. G., Circ. Res., 30, 44-54 (1972).
13. Droogmans G., Raeymaekers L., Casteels R., J. Gen. Physiol., 70, 129-148 (1977).
14. Furuta T., Shibata S., Kodama I., Yamada K., J. Cardiovasc. Pharmacol., 5, 836-841 (1983).
15. Shibata S., Wakabayashi S., Satake N., Hester R. K., Ueda S., Tomiyama, A., J. Pharmacol. Exp. Ther., 240, 16-22 (1987).
16. Eskinder H., Hillard C. J., Wilke R. A., Gross G. J., J. Cardiovasc. Pharmacol., 13, 502-507 (1989).
17. Sakata K., Karaki H., Br. J. Pharmacol., 102, 174-178 (1991).